AU2003236715A1 - Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema - Google Patents

Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema

Info

Publication number
AU2003236715A1
AU2003236715A1 AU2003236715A AU2003236715A AU2003236715A1 AU 2003236715 A1 AU2003236715 A1 AU 2003236715A1 AU 2003236715 A AU2003236715 A AU 2003236715A AU 2003236715 A AU2003236715 A AU 2003236715A AU 2003236715 A1 AU2003236715 A1 AU 2003236715A1
Authority
AU
Australia
Prior art keywords
orally
medicament
treatment
production
bone marrow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003236715A
Other languages
English (en)
Inventor
Nicolas Aigner
Cornelia Norden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU2003236715A1 publication Critical patent/AU2003236715A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003236715A 2002-06-06 2003-06-05 Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema Abandoned AU2003236715A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10225551.2 2002-06-06
DE10225551A DE10225551A1 (de) 2002-06-06 2002-06-06 Verwendung von oral verfügbaren Prostacyclinderivaten für die Herstellung eines Arzneimittels zur Behandlung von Krankheiten, die mit Knochenmarködemen assoziiert sind
PCT/EP2003/005990 WO2003103681A2 (de) 2002-06-06 2003-06-05 Verwendung von oral verfügbaren prostazyklinderivaten für die herstellung eines arzneimittels zur behandlung von krankheiten, die mit knochenmarködemen assoziert sind

Publications (1)

Publication Number Publication Date
AU2003236715A1 true AU2003236715A1 (en) 2003-12-22

Family

ID=29594336

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003236715A Abandoned AU2003236715A1 (en) 2002-06-06 2003-06-05 Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema

Country Status (9)

Country Link
EP (1) EP1515728A2 (de)
JP (1) JP2005536476A (de)
KR (1) KR20050007591A (de)
CN (1) CN1658882A (de)
AU (1) AU2003236715A1 (de)
CA (1) CA2488861A1 (de)
DE (1) DE10225551A1 (de)
WO (1) WO2003103681A2 (de)
ZA (1) ZA200500097B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2641393C (en) * 2006-02-03 2014-12-16 Scidose Llc Novel epoprostenol formulation and method of making thereof
TWI520740B (zh) * 2011-02-02 2016-02-11 模範健康科技私人企業有限公司 利用多硫酸化多醣之骨髓水腫（水腫）的治療
JP2020531549A (ja) * 2017-08-31 2020-11-05 シャリテ−ウニベルジテーツメディツィン ベルリン 易感染性患者における筋骨格系損傷の治癒不良を防ぐための免疫調節

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
EP0686036B1 (de) * 1992-08-07 1997-03-12 Schering Aktiengesellschaft Verwendung von prostanderivaten zur herstellung eines arzneimittels zur behandlung der chronischen polyarthritis
EP1016408B1 (de) * 1997-09-16 2006-04-19 Toray Industries, Inc. Neue pharnazeutische verwendung von c-c chemokin produktionsinhibitoren
WO2002026194A2 (en) * 2000-09-28 2002-04-04 Non-Invasive Monitoring Systems, Inc. External addition of pulses to fluid channels of body to release or suppress endothelial mediators and to determine effectiveness of such intervention

Also Published As

Publication number Publication date
KR20050007591A (ko) 2005-01-19
WO2003103681A2 (de) 2003-12-18
ZA200500097B (en) 2006-06-28
WO2003103681A3 (de) 2004-03-25
EP1515728A2 (de) 2005-03-23
CN1658882A (zh) 2005-08-24
DE10225551A1 (de) 2003-12-24
JP2005536476A (ja) 2005-12-02
CA2488861A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
AU2003302885A1 (en) Disposable diaper producing method
AU2003301347A1 (en) Methods for monitoring treatment of disease
AU2003219690A1 (en) Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
AU2003270903A1 (en) A video game for assisting healing of the human body
AU2003254553A1 (en) Medical implant
AU2003253106A1 (en) Medical implant
AU2003232258A1 (en) Medical implant
AU2002249111A1 (en) Process for the preparation of a medical implant
HK1087103A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
TWI345975B (en) Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
AU2003217275A1 (en) Azabicyclic compounds for the treatment of disease
AU2003221078A1 (en) Therapeutic composition for bone infectious disease
AU2003303217A1 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2003298719A1 (en) Treatment for sma disease
AU2003223780A1 (en) Treatment for pompe disease
AU2003236715A1 (en) Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema
IL162509A (en) Use of deoxypeganine for the production of a drug for treating clinical depression
AU2003209542A1 (en) Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
AU2003242517A1 (en) A handpiece for tissue treatment
AU2003256112A1 (en) Patient bed
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain
AU2003242538A1 (en) Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug
AU2003214317A1 (en) Use of a novel class of drugs for the treatment of parasitic diseases
AU2003227524A1 (en) Use of bisphosphonic acid derivatives for the treatment of calcium phrophosphated deposition disease and dental treatment
AU2003232698A1 (en) Use of a n,n'-dibenzyl-thiourea as medicine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase